Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin for Prevention of Recurrent AV Graft Thrombosis in Hemodialysis Patients
NCT01970280Phase 4Unknown
- Start
- Sep 2013
- Primary completion
- Nov 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in Arteriovenous graft thrombosis. Status: unknown.
02
Drugs
enoxaparin
03
Conditions
Arteriovenous graft thrombosis
Beyond the preview
Go deeper on NCT01970280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01970280.